Newsletter2025-01-21T12:29:11+01:00

NEWSLETTER

Unleash the Power of Knowledge in Renal Denervation

Are you ready to stay at the forefront of significant developments in the field of Renal Denervation? We invite you to join our exclusive newsletter community dedicated to advancing your expertise in this revolutionary area of medicine.

Stay Informed: Receive the latest research findings, clinical studies, and technological advancements related to Renal Denervation with the Paradise™ Ultrasound Renal Denervation system right in your inbox.
Global Perspectives: Gain insights from leading experts and pioneers in the field, offering diverse perspectives from around the world.
Event Updates: Stay updated on upcoming conferences, workshops, and events focused on Renal Denervation with the Paradise system, providing opportunities for networking and continued learning.

How to Subscribe

Signing up is quick and easy! Simply fill out the registration form with your name, email address, and profession. This newsletter is meant for health care professionals.

Once subscribed, you’ll receive a confirmation email with a link you need to confirm that you want to receive our news. Then you’ll be on your way to receive a wealth of information on Renal Denervation.

Recor-logo-orange-and-white_200x100

Privacy Statement | Terms & Conditions | Corporate Governance | Patents | Connect

Privacy Statement | Terms & Conditions | Corporate Governance | Patents | Connect

© 2025 Recor Medical Europe GmbH. All Rights Reserved. | Follow us on:

© 2025 Recor Medical Europe GmbH. All Rights Reserved.
Follow us on:

The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.

© 2025 Recor Medical, Inc. All rights reserved. The PARADISE™ system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted, per approved indications for use. For investigational use only in Japan. RECOR MEDICAL, PARADISE, HYDROCOOLING, SONOWAVE 360, RADIANCE, the GPS logo, and the Swirl logo are registered trademarks in the EU and the other countries, RECOR and the RADIANCE logo are also trademarks of Recor Medical, Inc. EMEA 03/2025

Important Safety Information
Prescription Only. Brief Summary – Prior to use, please reference the Instructions for Use

Indications for Use
The Paradise™ Ultrasound Renal Denervation System (Paradise™ System) is indicated to reduce blood pressure as an adjunctive treatment in hypertension patients in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure.

Results may vary. The most common risks include pain, vascular site injury and vasospasm. See full important safety information: https://www.recormedical.eu/paradise-ultrasound-rdn-system/#safety

Recor Medical, headquartered in Palo Alto, California, USA, a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd. recormedical.eu is Recor Medical, Otsuka Medical Devices Europe GmbH website (the Site). We control and operate this Site from Europe. This Site is intended for use by European residents only and contains information regarding the Paradise™ System, which is approved for sale in the EU and bears a CE mark.

Recor Medical Europe GmbH
Europa-Allee 52 · 60327 Frankfurt · Germany
Amtsgericht Frankfurt am Main: HRB 123214
Chief Executive Officers: Lara Barghout, Michael Jones, Ronan O`Connor